Lecture 15--HDL & Cholesterol Flashcards
Function of cholesterol
> Structural
>Precursor (vitamin D, steroid hormones, bile salts)
Briefly outline vit D synthesis
7-dehydrocholesterol –UV light (irradiated)–> conversion in liver & kidney–>CALCITRIOL (active form)
Briefly outline steroid synthesis
- *Cholesterol
- -(conversion)–>
- *PREGNENOLONE
- -(conversion in renal cortex)–>
- *Steroid hormones
What is the common intermediate in steroid synthesis from cholesterol?
PREGNENOLONE
Briefly outline bile salt synthesis from cholesterol?
Cholesterol --(conversion)--> PRIMARY BILE ACIDS --(conversion, intestines)--> SECONDARY BILE ACIDS
What is the conversion of the PRIMARY & SECONDARY bile acids?
Primary –> Secondary
Cholic Acid ==> deoxycholic acid
Chenodeoxycholid Acid ==> Lithocholic Acid
What are the primary bile acids
1) cholic Acid
2) CHENODEOXYcholic Acid
What are the secondary bile acids?
1) DEOXYcholic acid
2) LITHOcholic acid
What causes Smith-Lemli-Optiz syndrome?
1) Due to a MUTATION IN DHCR7 gene =>
2) Can’t synthesise 7-DEHYDROCHOLESTEROL REDUCTASE
3) Means UNABLE TO SYNTHESISE CHOLESTEROL
Caused by mutation in gene DHCR7 which encodes 7-dehydrocholesterol reductase. In the absence of this enzyme cholesterol cannot be synthesised.
7-dehydrocholesterol reductase
essential enzyme in the synthesis of cholesterol
Mutation in DHCR7 gene leads to inability to synthesise cholesterol (Smith-Lemli-Optiz syndrome)
Symptoms of Smith-Lemli-Opitz Syndrome
+ Treatment
1) Cleft Palate
2) Microcephaly (small head)
3) Abnormal brain development
4) Dysmyelination
5) Congenital heart defects
6) Limb malformation
Treatment with dietary cholesterol supplementation
Cholesterol biosynthesis by what pathway?
The MEVALONATE PATHWAY
What is the MEVALONATE PATHWAY?
Cholesterol biosynthesis
Acetyl CoA –(HMG CoA Synthase)–> HMG CoA –(HMG CoA Reductase)–> Mevalonate –>–>Cholesterol
Cholesterol regulation by cells –HIGH CHOLESTEROL
ApoB100 binds to receptor
Internalised
Free cholesterol moves to Golgi
EFFECTS:
(1) Diminish HMG CoA REDUCTASE (=reduced mevalonate pathway/chol BIOSYNTHESIS from acetyl CoA)
(2) Diminish expression of LDL RECEPTOR (=diminish UPTAKE by cells)
(3) Increase Expression of ACAT (converts free chol–>esterified Chol = increases STORAGE)
Cholesterol regulation by cells –LOW CHOLESTEROL
=> transcription factors translocate to the nucleus when there is an absence of cholesterol.
(1) INSIG dissociates from ER
(2) SREBP cleaves from INSIG
(3) SREBP complexes with SCAP
(4) SREBP-SCAP move to golgi
(5) From golgi SREBP/SCAP move to nucleus (regulate cool synthesis)
INSIG
Nuclear transcription factor
Tethered to ER membrane when cool is present, dissociates when low cholesterol
SREBP
‘Sterol regulatory element binding protein’
LOW CHOL: Dissociates from INSIG, associates with SCAP & moves to golgi then to nucleus where it regulates cholesterol synthesis
Statin drugs ____________ b/c they have a _______ effect. What does this mean?
Statin drugs REDUCE THE RISK OF CVD b/c they have a PLEIOTROPIC effect.
They don’t just block HMG CoA reductase (=reducing cholesterol synthesis) they also:
1Diminish ACTIVATION of PLATELETS
2Diminish the THROMBOTIC EFFECT
3Diminish PROLIFERATION of smooth muscle cells
4Increase PLAQUE STABILITY
Cholesterol homeostasis
\_\_\_\_g/day (diet) \_\_\_\_g/day (synthesised) \_\_\_\_g/day (secreted to bile salts) \_\_\_\_g/day (secreted to bile) \_\_\_\_g/day (secreted to VLDL)
NET GAIN _____ g/day
NET LOSS ____g/day
NET (TOTAL)____g/day
+ 0.5 g/day (diet)
+ 1 g/day (synthesised)
- 0.5 g/day (secreted to bile salts)
- 1.0 g/day (secreted to bile)
- 1.0 g/day (secreted to VLDL)
NET GAIN 1.5 g/day
NET LOSS -2.5 g/day
NET (TOTAL) -1.0 g/day